{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:26:28Z","timestamp":1788387988655,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.yebeh.2003.10.011","type":"journal-article","created":{"date-parts":[[2003,12,11]],"date-time":"2003-12-11T11:48:51Z","timestamp":1071143331000},"page":"31-36","source":"Crossref","is-referenced-by-count":20,"title":["Long-term tolerability of lamotrigine: data from a 6-year continuation study"],"prefix":"10.1016","volume":"5","author":[{"given":"Edward","family":"Faught","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumisuke U.","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Schachter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Messenheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda P.","family":"Womble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2003.10.011_BIB1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1528-1157.1989.tb05309.x","article-title":"Controlled trial of lamotrigine (Lamictal) for refractory partial seizures","volume":"30","author":"Jawad","year":"1989","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0920-1211(90)90077-9","article-title":"A randomized, double-blind, placebo-controlled, add-on trial of lamotrigine in patients with severe epilepsy","volume":"6","author":"Sander","year":"1990","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.yebeh.2003.10.011_BIB3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0920-1211(90)90099-H","article-title":"A randomized double-blind crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures","volume":"7","author":"Loiseau","year":"1990","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.yebeh.2003.10.011_BIB4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/jnnp.56.5.448","article-title":"Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant partial seizures","volume":"56","author":"Schapel","year":"1993","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB5","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1212\/WNL.43.11.2284","article-title":"Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures","volume":"43","author":"Matsuo","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB6","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1528-1157.1994.tb02920.x","article-title":"Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, crossover trial","volume":"35","author":"Messenheimer","year":"1994","journal-title":"Epilepsia"},{"issue":"Suppl 5","key":"10.1016\/j.yebeh.2003.10.011_BIB7","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1111\/j.1528-1157.1999.tb00917.x","article-title":"Lamotrigine","volume":"40","author":"Matsuo","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB8","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1212\/WNL.51.4.1018","article-title":"An active-control trial of lamotrigine monotherapy for partial seizures","volume":"51","author":"Gilliam","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB9","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(95)90581-2","article-title":"Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy","volume":"345","author":"Brodie","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1528-1157.1999.tb05562.x","article-title":"Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin","volume":"40","author":"Steiner","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0387-7604(99)00023-6","article-title":"Lamotrigine in typical absence epilepsy","volume":"21","author":"Buoni","year":"1999","journal-title":"Brain Dev."},{"key":"10.1016\/j.yebeh.2003.10.011_BIB12","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox\u2013Gastaut syndrome","volume":"337","author":"Motte","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yebeh.2003.10.011_BIB13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00002018-199818040-00004","article-title":"Safety review of adult clinical trial experience with lamotrigine","volume":"18","author":"Messenheimer","year":"1998","journal-title":"Drug Saf."},{"key":"10.1016\/j.yebeh.2003.10.011_BIB14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1055\/s-2008-1073041","article-title":"Intractable epilepsy in children: the efficacy of lamotrigine treatment, including non-seizure-related benefits","volume":"25","author":"Uvebrant","year":"1994","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1528-1157.1999.tb00805.x","article-title":"Lamictal monotherapy for typical absence seizures in children","volume":"40","author":"Frank","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0896-6974(95)00034-B","article-title":"A six-month, placebo-controlled safety and tolerance study","volume":"8","author":"Schachter","year":"1995","journal-title":"J. Epilepsy"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB17","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1528-1157.1996.tb00038.x","article-title":"Lamotrigine high-dose tolerability and safety in patients with epilepsy: a double-blind, placebo-controlled, 11-week study","volume":"37","author":"Matsuo","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1212\/WNL.56.2.172","article-title":"Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy","volume":"56","author":"Biton","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.54.4.973","article-title":"Stable weight during lamotrigine therapy: a review of 32 studies","volume":"54","author":"Devinsky","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1528-1157.1999.tb00807.x","article-title":"Lamotrigine-associated rash: risk\/benefit considerations in adults and children","volume":"40","author":"Guberman","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB21","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1528-1157.1997.tb01252.x","article-title":"Safety of long-term lamotrigine in epilepsy","volume":"38","author":"Mackay","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB22","first-page":"237","article-title":"Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom","volume":"42","author":"Wong","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2003.10.011_BIB23","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1017\/S0317167100034910","article-title":"Rash in adult and pediatric patients treated with lamotrigine","volume":"25","author":"Messenheimer","year":"1998","journal-title":"Can J. Neurol. Sci."},{"key":"10.1016\/j.yebeh.2003.10.011_BIB24","unstructured":"Lamictal\u00ae (lamotrigine) Tablets Prescribing Information. GlaxoSmithKline, June 2003"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505003003007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505003003007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T08:26:47Z","timestamp":1550305607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505003003007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S1525505003003007"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2003.10.011","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}